CWC15 is a conserved eukaryotic protein encoded by the CWC15 gene located on human chromosome 11q21 (NCBI Gene ID: 51503) . Key features include:
| Property | Detail |
|---|---|
| Molecular Weight | 26.6 kDa |
| UniProt ID | Q9P013 |
| Cellular Localization | Nucleus, nuclear speckles, and mitochondria |
| Function | Facilitates mRNA splicing via spliceosome; modulates miRNA biogenesis |
CWC15 stabilizes spliceosomal components and interacts with miRNA-processing proteins like HYL1 and SERRATE (SE) to regulate pri-miRNA transcription and processing .
Commercial CWC15 antibodies are primarily monoclonal or polyclonal reagents validated for diverse applications:
CWC15 antibodies are utilized in multiple experimental workflows:
Mechanism: CWC15 binds MIR gene promoters to enhance RNA Polymerase II occupancy, boosting pri-miRNA transcription. It also stabilizes HYL1-pri-miRNA interactions, improving processing efficiency .
Regulation: CWC15 promotes phosphorylation and proteasomal degradation of SERRATE (SE), preventing excessive SE accumulation that disrupts miRNA maturation .
Neurological Disorders: CWC15 is linked to ADHD and conduct disorder, though mechanistic insights remain under investigation .
Developmental Defects: CWC15 knockdown in Arabidopsis causes growth abnormalities and embryo lethality, underscoring its essential role .
Storage: Antibodies are typically supplied in PBS with 0.1% sodium azide and require storage at 4°C .
Controls: Blocking peptides (e.g., sc-390450 P) are available for competition assays .
Current studies focus on: